Vignesht Packiam News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vignesht packiam. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vignesht Packiam Today - Breaking & Trending Today

Testicular Cancer: Expert Advice for Early Detection

Vignesh T. Packiam, MD, director of Clinical and Translational Research in Urologic Oncology and a urologic oncologist in the Urologic Oncology Program at Rutge ....

United States , Vignesht Packiam , Translational Research In Urologic Oncology , Rutgers Cancer Institute Of New Jersey , American Cancer Society , Cancer Center , Rwjbarnabas Health , New Brunswick , American Cancer , Translational Research , Urologic Oncology , Urologic Oncology Program , Rutgers Cancer Institute , New Jersey , Comprehensive Cancer Center ,

Gemcitabine-Docetaxel May Be a Feasible Alternative to BCG for High-Risk NMIBC

Investigators report their early clinical experience using intravesical sequential gemcitabine-docetaxel as first-line therapy for high-risk nonmuscle-invasive bladder cancer. Intravesical sequential gemcitabine-docetaxel may be a feasible alternative to BCG for high-risk nonmuscle-invasive bladder cancer (NMIBC). ....

Wake Forest University , North Carolina , United States , Winston Salem , Vignesht Packiam , Justin Manuel Refugia , Society Of Urologic Oncology , Wake Forest University School Of Medicine , University Of Iowa , Urologic Oncology , Wake Forest University School , Cancers Symposium , Iowa City ,

Gemcitabine-Docetaxel May Be a Feasible Alternative to BCG for High-Risk NMIBC

Investigators report their early clinical experience using intravesical sequential gemcitabine-docetaxel as first-line therapy for high-risk nonmuscle-invasive bladder cancer. Intravesical sequential gemcitabine-docetaxel may be a feasible alternative to BCG for high-risk nonmuscle-invasive bladder cancer (NMIBC). ....

Winston Salem , North Carolina , United States , Wake Forest University , Justin Manuel Refugia , Vignesht Packiam , Wake Forest University School Of Medicine , University Of Iowa , Society Of Urologic Oncology , Urologic Oncology , Wake Forest University School , Cancers Symposium , Iowa City ,

Amid drug shortage, chemotherapy regimen a viable alternative for high-risk bladder cancer

The combination of gemcitabine and docetaxel conferred superior high-grade recurrence-free survival compared with standard therapy among adults with high-risk nonmuscle-invasive bladder cancer, results of a retrospective study showed.Patients who received the chemotherapy combination also had a lower frequency of treatment discontinuation than those who received bacillus Calmette-Guérin (BCG), ....

Vignesht Packiam , Richardd Williams , Michael Odonnell , University Of Iowa Health Care , University Of Iowa , Iowa Health Care , Michaelo Donnell ,

Sequential Gemcitabine+Docetaxel an Effective Alternative to BCG in High-Risk NMIBC

Investigators compared the benefits of gemcitabine and docetaxel vs Bacillus Calmette-Guérin (BCG) in nonmuscle invasive bladder cancer (NMIBC). ....

Vignesht Packiam , University Of Iowa , University Of Iowa Hospitals , Iowa Hospitals , Iowa City ,